Neurogene Inc. NGNE
NASDAQ · United States · Health Technology
$25.65-0.90 (-3.39%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -1.53 | -1.42 | -7.5% | $0 | — | +1.2%$36.55→$36.98 |
| Q1 2026 | 2026-05-12 | -1.39 | -1.35 | -3.0% | — | — | +5.6%$30.89→$32.62 |
| Q4 2025 | 2026-03-24 | -1.13 | -1.24 | +8.9% | — | — | +13.8%$19.36→$22.03 |
| Q3 2025 | 2025-11-13 | -0.99 | -1.26 | +21.4% | — | — | -26.7%$31.08→$22.77 |
| Q1 2025 | 2025-05-09 | -1.08 | -0.92 | -17.4% | — | — | — |
| Q4 2024 | 2025-03-24 | -0.99 | -1.13 | +12.4% | — | — | — |
| Q3 2024 | 2024-11-18 | -1.19 | -1.22 | +2.5% | — | — | — |
| Q2 2024 | 2024-08-09 | -1.09 | -1.03 | -5.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.